- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01479491
Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan
October 18, 2012 updated by: GlaxoSmithKline
Observational Database Study on the Incidence of Intussusception in Children Aged < 12 Months in Japan
This study aims to analyse baseline data on IS in order to monitor the possibility of increased risk of IS in children aged <12 months after introduction of the Rotarix vaccination in Japan.
Study Overview
Study Type
Observational
Enrollment (Actual)
54
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Children aged <12 months presenting with IS and covered by the JMDC-MDB database from January 2005 to April 2011.
Description
Inclusion Criteria:
- A male or female infant aged < 12 months at the time of IS diagnosis and affiliated to the JMDC-MDB database.
- An IS case should be identified as per the ICD-10 diagnostic code-K56.1 (any-field listed), examination codes, and procedural codes.
Exclusion Criteria:
Not applicable
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Case Group
Children aged < 12 months presenting with IS and covered by the Japan Medical Data Centre Company Limited (JMDC), Tokyo referred to as the JMDC Medical Data Bank (JMDC-MDB).
|
Data source will be the Japan Medical Data Centre Company Limited (JMDC) - JMDC Medical Data Bank (JMDC-MDB) database.
Aggregated data (age in months and years and gender) for all subjects recorded in the database and subject-level data for IS cases will be extracted from the database.
This database will be reviewed to extract data for the period between January 2005 and April 2011.
Cases of IS will be identified using the International Classification of Diseases-10 (ICD-10) diagnostic codes, examination codes and procedural codes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Occurrence of IS in subjects aged < 12 months
Time Frame: Between January 2005 and April 2011 (6 years)
|
Between January 2005 and April 2011 (6 years)
|
Occurrence of age-specific and gender-specific incidence of IS among subjects aged < 12 months in Japan
Time Frame: Between January 2005 and April 2011 (6 years)
|
Between January 2005 and April 2011 (6 years)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of IS cases hospitalized more than once among subjects aged < 12 months.
Time Frame: Between January 2005 and April 2011 (6 years)
|
Between January 2005 and April 2011 (6 years)
|
Occurrence of IS cases by calendar months and year among subjects aged < 12 months
Time Frame: Between January 2005 and April 2011 (6 years)
|
Between January 2005 and April 2011 (6 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
November 22, 2011
First Submitted That Met QC Criteria
November 23, 2011
First Posted (Estimate)
November 24, 2011
Study Record Updates
Last Update Posted (Estimate)
October 22, 2012
Last Update Submitted That Met QC Criteria
October 18, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 116259
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intussusception
-
Hongkui Yu, MDRecruitingIleocolic IntussusceptionChina
-
GlaxoSmithKlineCompletedRotavirus Vaccines | Intussusception (IS)Mexico
-
National Children's Hospital, VietnamVinmec Research Institute of Stem Cell and Gene TechnologyCompletedIntussusceptionVietnam
-
Minia UniversityCompleted
-
National Children's Hospital, VietnamVinmec Research Institute of Stem Cell and Gene TechnologyCompleted
-
Minia UniversityUnknown
-
GlaxoSmithKlineCompletedIntussusceptionSingapore
-
University of Roma La SapienzaCompletedRectocele | Rectal Prolapse | Intussusception of Rectum
-
Sanjeev KharelTribhuvan University Teaching Hospital, Institute Of Medicine.CompletedIntussusceptionNepal
-
Baskent UniversityRecruiting
Clinical Trials on Data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
University Hospital, Basel, SwitzerlandRecruitingInfections With CPBSwitzerland
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Women and Infants Hospital of Rhode IslandTerminated
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance